Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial (Q33926135)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial |
scientific article |
Statements
1 reference
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial (English)
1 reference
Mario Sznol
1 reference
Roy S Herbst
1 reference
Sarah B Goldberg
1 reference
Scott N Gettinger
1 reference
Amit Mahajan
1 reference
Anne C Chiang
1 reference
Apostolos John Tsiouris
1 reference
Justine Cohen
1 reference
Alexander Vortmeyer
1 reference
Lucia Jilaveanu
1 reference
James Yu
1 reference
Upendra Hegde
1 reference
Stephanie Speaker
1 reference
Matthew Madura
1 reference
Amanda Ralabate
1 reference
Angel Rivera
1 reference
Elin Rowen
1 reference
Heather Gerrish
1 reference
Xiaopan Yao
1 reference
Veronica Chiang
1 reference
Harriet M Kluger
1 reference
1 reference
Identifiers
1 reference